NovaSight

Private

IsraelHealthcare & Life Scienceshttps://nova-sight.com/

Last Round

Series B

Mar 1, 2024

Total Funding Raised

$23M

Company Overview

NovaSight is a therapeutic devices company that develops eye-tracking-based solutions for the diagnosis and treatment of pediatric vision disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

amblyopia treatmentlazy eye treatmentdigital therapeuticsDTxeye-tracking technologypediatric vision careFDA cleared devicedichoptic therapyremote patient monitoringmedical AIvision therapyvision diagnosticstelemedicinemyopia control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovaSight Comps

Public and private peers based on sector, stage, and business model.

NovaSight comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NovaSight Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Mar 1, 2024
Series A	Jul 13, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Ran Yam

CEO & Co-founder

Founding Team

NovaSight Investors

Notable investors and investment history

NovaSight investors
Investor	Rounds
Rimonci	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 9, 2025
Monthly visitors increased 264% MoM, reaching 8.4K.
May 2, 2025
Monthly visitors grew 117% MoM, reaching 2.6K.

View all signals

NovaSight Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NovaSight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NovaSight's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Employee Range16

Year Founded2016

Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.